A Phase II trial of aprinocarsen, an antisense...

Cancer 2004 Vol. 100; Iss. 2

A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C α, administered as a 21-day infusion to patients with advanced ovarian carcinoma

Ranjana Advani, Prema Peethambaram, Bert L. Lum, George A. Fisher, Lynn Hartmann, Harry J. Long, Joanne Halsey, Jon T. Holmlund, Andrew Dorr, Branimir I. Sikic
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
100
Year:
2004
Language:
english
Pages:
6
DOI:
10.1002/cncr.11909
File:
PDF, 77 KB
english, 2004
Conversion to is in progress
Conversion to is failed